medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2020, Number 1

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2020; 19 (1)

Anesthetic approach on a pediatric patient with hereditary microspherocytosis

Sánchez TM, Cruz CM, Azcuy BA, Díaz FL, Garcés TMC

Language: Spanish
References: 12
Page: 1-10
PDF size: 288.63 Kb.


ABSTRACT

Introduction: Hereditary spherocytosis (HS) is a hemolytic anemia of frequent occurrence, in which there are qualitative or quantitative defects of some erythrocyte membrane proteins that lead to the formation of sphere-shaped red blood cells, which are osmotically fragile, and that are selectively trapped and destroyed in the spleen, with variable and more frequent incidence in patients with European descent.
Objective: To describe the clinical and anesthesiological behavior of a pediatric patient with a diagnosis of hereditary microspherocytosis electively programmed for a surgical procedure.
Development: A clinical case of a school-age patient with a diagnosis of hereditary microspherocytosis was presented. The patient underwent conventional elective total splenectomy. Pain was as the main sign on palpation to the left hypochondrium. The case was conducted with total intravenous anesthesia, with good surgical clinical results, using propofol at a rate of 3 mcg/mL and ketamine at 0.2 mg/mL. The strategy was based on five key aspects: avoid hypoxia, hypothermia, acidosis, reduce blood loss, as well as proper control of postoperative pain. Associated with the above-mentioned, close monitoring is essential, as these patients may manifest hemolytic and aplastic crisis.
Conclusions: The perioperative management of the patient with hereditary spherocytosis depends on the severity of the clinical status, the anemia and its repercussion, and the degree of hemolysis. Total intravenous anesthesia is a safe technique for the treatment of patients with hereditary spherocytosis.


REFERENCES

  1. Donato H, Crisp RL, Rapetti MC, García E, Attie M. Esferocitosis hereditaria. Revisión. Parte I. Historia, demografía, etiopatogenia y diagnóstico. Arch Argent Pediatr. 2015 [acceso: 15/03/2019];113(1):69-80. Disponible en: https://www.sap.org.ar/docs/ publicaciones/archivosarg/2015/v113n1a22.pdf

  2. Kocamer Şimşek B, Baydilek Y, Ziya Şahin A, Darıcı H. Anesthetic Management with Total İntravenous Anesthesia in Hereditary Spherocytosis: A Case Report. Eur J Ther. 2018 [acceso: 15/03/2019];24(1):64-66. Disponible en: http://www.scielo.org.ar/ pdf/aap/v113n2/v113n2a25.pdf

  3. Goldbard Rochman D, Casaubon Garcín PR, Baptista González H, Lamshing Salinas P. Esplenectomía en un lactante menor por esferocitosis hereditaria severa. AnMed (Mex). 2017 [acceso: 15/03/2019];62(4):283-88. Disponible en: http://www.medigraphic.com/ pdfs/abc/bc-2017/bc174j.pdf

  4. Kulkarni K, Deshpande S, Talakatti S. Anaesthetic Management of a Child with Hereditary Spherocytosis for Splenectomy. EC Anaesthesia. 2019 [acceso: 15/03/2019];5(2):14-19. Disponible en: https://www.ecronicon.com/ecan/pdf/ECAN-04-00123.pdf

  5. Donato H, Crisp RL, Rapetti MC, García E, Attie M. Esferocitosis hereditaria. Revisión. Parte II. Manifestaciones clínicas, evolución, complicaciones y tratamiento. Arch Argent Pediatr. 2015 [acceso: 15/03/2019];113(2):168-76. Disponible en: http://www.scielo.org.ar/pdf/aap/v113n2/v113n2a25.pdf

  6. Chaithanya K, Narasimha Reddy P, Gandra S, Srikanth A. Anaesthetic management of a case of hereditary spherocytosis forsplenectomy and cholecystectomy. Indian J Anaesth. 2014 [acceso: 15/03/2019];58(3):343-45. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091009/

  7. Tsui PY, Chu MC. Ketamine: an old drug revitalized in pain medicine. BJA Education. 2016 [acceso: 23/01/2019];44(2):1-4. Disponible en: https://academic.oup.com/bjaed/article/17/3/84/2907830

  8. Squire Y, Laxton C. Blood Conservation Techniques. ATOTW 390. 2018 [acceso: 15/03/2019];58(3):1-7. Disponible en: https://www.wfsahq.org/components/ com_virtual_library/media/8d6712e97e44cd3c3c2af5cc1cbffc00-atow-390-00-01.pdf

  9. Malliwal A, Mehta S, Bakhshi R, Mahapatra B. Anaesthetic considerations for patient of Hereditary Spherocytosis forsplenectomy and cholecystectomy: A case report. Indian J Anaesth. 2014 [acceso: 15/03/2019];4(1):295-97. Disponible en: http://ijbamr.com/ pdf/December%202014%20295-297%20AA.pdf

  10. Espinoza de los Monteros Estrada I, Cabrera Joachin CM, Rosales Gutiérrez AO, Espinoza de los Monteros Estrada GK. Valores óptimos de hemoglobina en el perioperatorio ¿más es mejor? Rev Mex anestesiol. 2016 [acceso: 15/03/2019];39(2):152-55. Disponible en: http://www.medigraphic.com/pdfs/rma/cma-2016/cma162h.pdf

  11. Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, et al. Hematologic outcomes after total splenectomy and partialsplenectomy for congenital hemolytic anemia. J Pediatr Surg. 2016 [acceso: 15/03/2019];51(1):122-27. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.24713

  12. Bharne S, Gowler V, Dias M. Anesthetic management of a patient with hereditary spherocytosis for laparoscopic cholecystectomy and splenectomy. Saudi J Anaesth. 2012 [acceso: 15/03/2019];6(4):438-39. Disponible en: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3591577/




2020     |     www.medigraphic.com